Sensible MedicineThis Fortnight in Medicine XXII1×0:00Current time: 0:00 / Total time: -39:33-39:33Audio playback is not supported on your browser. Please upgrade.This Fortnight in Medicine XXIIDo GLP-1s help substance use disorder? Does PCI of non-culprit vessels help people with STEMI?Adam Cifu, MD, John Mandrola, and Andrew J FoyMar 24, 2026ShareGlucagon-like peptide-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes: cohort studyImmediate or Deferred Nonculprit-Lesion PCI in Myocardial InfarctionAndrew’s previous SM post on the subject: How a Meta-Analysis can Mislead—The Story of Complete vs Culprit-only PCI in STEMIAnd, a bunch of the other studies we discussed.Complete Revascularization with Multivessel PCI for Myocardial InfarctionFFR-Guided Complete or Culprit-Only PCI in Patients with Myocardial InfarctionInitial Invasive or Conservative Strategy for Stable Coronary DiseaseDiscussion about this episodeCommentsRestacksSensible MedicineCommon sense and original thinking in bio-medicineA platform for diverse views and debateCommon sense and original thinking in bio-medicine A platform for diverse views and debateSubscribeListen onSubstack AppRSS FeedAppears in episodeAndrew J FoyWrites Andrew J Foy SubscribeAdam Cifu, MDJohn MandrolaRecent EpisodesThis Fortnight in Medicine XXIMar 11 • Adam Cifu, MD, John Mandrola, and Andrew J FoyGoing Beyond "AI in Medicine"Mar 4 • Adam Cifu, MDThis Fortnight in Medicine XXFeb 25 • Adam Cifu, MD, John Mandrola, and Andrew J FoyAlternative Modalities for Breast Cancer ScreeningFeb 18 • Adam Cifu, MDThis Fortnight in Medicine XIXFeb 11 • Adam Cifu, MD, John Mandrola, and Andrew J FoyThis Fortnight in Medicine XVIIIJan 28 • Adam Cifu, MD, John Mandrola, and Andrew J FoyWhen to treat (or not treat) a high cholesterol Jan 18 • John Mandrola